XOMA ROYALTY CORPORATION (XOMA)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$40.170.00%
Close 2026-07-14 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · XOMA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 48.6 | 52.1 | 28.5 | 4.8 | 6.0 | 38.2 | 29.4 | 18.4 | 5.3 | 52.7 | 5.6 | 55.4 | 18.9 | 35.5 | 33.8 | 58.2 |
| Total Revenues | 48.6 | 52.1 | 28.5 | 4.8 | 6.0 | 38.2 | 29.4 | 18.4 | 5.3 | 52.7 | 5.6 | 55.4 | 18.9 | 35.5 | 33.8 | 58.2 |
| Cost of Revenues | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.1 | — |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | — | — | — | — | — | — | — | — | — | — | 18.3 | 20.6 | 19.9 | 18.5 | 16.9 | 24.0 |
| R&D Expenses | 0.5 | 1.7 | 2.9 | 0.1 | 0.2 | 0.2 | 0.2 | 1.3 | 1.7 | 7.9 | 44.2 | 70.9 | 80.7 | 74.9 | 68.5 | 68.1 |
| Operating Income | 5.0 | 11.4 | (40.0) | (41.8) | (17.4) | 17.5 | 12.4 | (3.9) | (16.9) | 17.0 | (61.6) | (39.7) | (81.8) | (58.2) | (56.6) | (34.0) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | — | — | — | 4.3 | 4.6 | 4.4 | 2.5 |
| Asset Writedown | — | — | — | 14.3 | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 2.5 | — |
| EBT, Incl. Unusual Items | — | 31.8 | (19.5) | (40.8) | (17.1) | 15.9 | 11.8 | (2.0) | (13.4) | 16.3 | — | (20.6) | (38.3) | (124.1) | (71.1) | (32.7) |
| Income Tax Expense | — | 0.1 | (5.7) | 0.0 | (0.0) | 0.1 | (1.5) | (0.1) | (0.1) | 1.7 | 0.0 | (0.0) | 0.0 | (0.0) | (0.1) | 0.0 |
| Net Income | ||||||||||||||||
| Net Income | 33.8 | 31.7 | (13.8) | (40.8) | (17.1) | 15.8 | 13.3 | (2.0) | (13.3) | 14.6 | (53.5) | (20.6) | (38.3) | (124.1) | (71.1) | (32.7) |
| Per Share | ||||||||||||||||
| Basic EPS | 2.84 | 1.53 | (1.65) | (4.04) | (1.98) | 0.69 | 0.82 | — | (1.59) | 0.75 | (8.89) | (3.50) | (7.13) | — | — | — |
| Diluted EPS | 1.94 | 1.46 | (1.65) | (4.04) | (1.98) | 0.65 | 0.78 | — | (1.59) | 0.73 | (8.89) | (3.50) | (13.49) | — | — | — |
| Revenue per Share | 2.79 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 11.9 | 12.1 | 11.7 | 11.5 | 0.0 | 11.3 | 10.7 | — | 8.4 | 7.6 | 6.0 | 5.9 | 5.4 | — | — | 0.0 |
| Diluted Weighted Avg Shares | 17.4 | 18.0 | 11.7 | 11.5 | 0.0 | 12.2 | 11.5 | — | 8.4 | 8.0 | 6.0 | 5.9 | 5.8 | — | — | 0.0 |
| Supplemental | ||||||||||||||||
| EBITDA | — | — | — | — | — | — | 12.4 | (3.9) | (16.8) | 17.3 | (60.8) | (38.2) | (79.9) | (55.3) | (52.5) | (28.6) |
| EBIT | 5.0 | 11.4 | (40.0) | (41.8) | (17.4) | 17.5 | 12.4 | (3.9) | (16.9) | 17.0 | (61.6) | (39.7) | (81.8) | (58.2) | (56.6) | (34.0) |
| Effective Tax Rate | — | — | — | 0.0% | 0.1% | 0.6% | -12.7% | 4.9% | 0.7% | 10.2% | — | 0.1% | 0.0% | 0.0% | 0.1% | -0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.